Gain Therapeutics director Eric Richman resigns from board without disagreement; board reduced to seven

Gain Therapeutics, Inc.

Eric Richman resigned from the Board effective October 6, 2025.
Resignation was not due to any disagreement with company operations, policies, or practices.
Board size reduced from eight to seven members on October 7, 2025.

item 5.02

Gain Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-098376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.